Matthias Versele Overview
- Firm
- CD3 Leuven
- Primary Position
-
Executive Direct...
Matthias Versele General Information
Biography
Dr. Matthias Versele serves as Executive Director Drug Discovery Biology at CD3 Leuven. In 2017, he joined CD3 from Janssen, where he was an associate scientific director in the Oncology discovery group. He was a core member of the hematologic disease area stronghold, responsible for identifying and validating novel drug targets, and leading multiple discovery projects from hit identification to delivering a clinical candidate. In addition, he was the preclinical lead for Janssen during the clinical development of the covalent BTK inhibitor, ibrutinib (Imbruvica®), and contributed to the identification of clinically meaningful mechanisms of primary and acquired resistance, and the subsequent initiation of follow-on discovery projects. He joined Janssen in 2006, after a post-doctoral training at UC Berkeley and a PhD in biochemistry at KU Leuven.
Contact Information
Address
- Bio-incubator 2
- Gaston Geenslaan 2
- 3001 Leuven
- Belgium
Matthias Versele Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
CD3 Leuven | Investor | Executive Director Drug Discovery Biology | Leuven, Belgium | Venture Capital |
Matthias Versele FAQs
-
Who is Matthias Versele?
Dr. Matthias Versele serves as Executive Director Drug Discovery Biology at CD3 Leuven.
-
How much does Matthias Versele typically invest?
Matthias Versele's median deal size is
. -
What is Matthias Versele’s main position?
Matthias Versele’s primary position is Executive Director Drug Discovery Biology.
-
What are the contact details for Matthias Versele?
Matthias Versele’s email address is mv
and his phone number is +32 016 .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »